Niraparib and Temozolomide in Patients Glioblastoma
Niraparib and Temozolomide in Patients Glioblastoma
Not yet recruiting · NCT06258018 · Registry updated 2024-08-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Niraparib and Temozolomide in Patients Glioblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, malignant glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Phase 1 / Phase 2 | 2024-08-30 | NCT06258018 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Armando Santoro, MD | 1 |
| GlaxoSmithKline | 294 |
| Istituto Clinico Humanitas | 69 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Istituto Clinico Humanitas | Rozzano | Italy | 8 |